SBIR/STTR Research Award

Linkage-specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease

Award identifier 81db97045ba186e2cb4cca3f5b8f0721fb0ce8c3600fb56ab8cf5e54a180d5cdAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,662

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LIFESENSORS, INC.
Proposal award date
2016-09-01
Contract end date
2018-08-31
UEI
ECPPNPPB5U31
Solicitation number
PAR15-091
Topic code
NIA

Research abstract

Linkage specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease Abstract Despite an intensive effort by the government pharmaceutical companies and academic groups the diagnosis and treatment of Alzheimerandapos s disease remains elusive The incidence of Alzheimerandapos s disease is predicted to increase reaching more than million cases in USA by Thus the development of quantitative simple and reproducible diagnostic markers is extremely important Current methods for diagnosis of Alzheimerandapos s disease are dependent on clinical and neuropsychological assessment cerebrospinal fluid CSF analysis and brain imaging procedures all of which have significant cost and access to care barriers Thus the need for simple blood based biomarkers has never been greater We hypothesize that dysfunction in the ubiquitin proteasome pathway occurs decades before the clinical manifestation of Alzheimerandapos s disease symptoms Neurons generally do not divide and their survival depends heavily on the removal of misfolded proteins The first step in neurodegenerative disease begins with a diminished response to unfolded protein removal and proteasomal dysfunction Therefore neuronal diseases are marked by the appearance or change in pattern of ubiquitylated proteins the main hypothesis of this proposal which describes a unique combination of affinity purification of ubiquitylated proteins and mass spectroscopy approaches to detect ubiquitylated proteins and also determine the nature of the poly ubiquitin chain linkage Although the roles of the ubiquitin pathway in cell physiology and pathology have been recognized for the last three decades surprisingly there are no reliable and sensitive methods available to monitor patterns of ubiquitylation The development of this technology will enable clinicians to make early diagnoses of Alzheimerandapos s disease facilitate the discovery of disease modifying drugs and open doors for cell biologists to rapidly identify patterns of poly ubiquitylated proteins in tissues cells or body fluids PUBLIC HEALTH SIGNIFICANCE The proposed studies are based on the hypothesis that changes in the pattern of ubiquitylation of certain proteins both in extent and in the structure of the polyubiquitin chains appear early on in the onset of neurodegenerative diseases especially Alzheimers Disease AD Identification of these changes by a combination of linkage specific polyubiquitin affinity based purification matrices and high resolution quantitative mass spectrometry should provide lead markers for the development of diagnostic tests for the early detection of AD and new therapeutic approaches

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

40 SBIR/STTR records share this UEI (1989–2024). Reported award amounts total $22,492,305. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.